Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease.

Kallikreins are serine proteases that release kinins from kininogens. Kinins, via their effects on cardiovascular and renal function, may be involved in the pathogenesis of hypertension and renal failure. Two groups of kallikreins exist, glandular or tissue kallikrein and plasma kallikrein. In this study, we examined the human plasma kallikrein gene KLK3 to determine whether it contributed to end-stage renal disease (ESRD) susceptibility. We identified two novel polymorphic sequences closely linked to the KLK3 gene, designated KLK3b and KLK3c (heterozygosities: 0.64 to 0.68 and 0.48 to 0.52, respectively). We mapped the KLK3 gene and the marker KLK3c to the long arm of human chromosome 4 between F11 and D4S426 using a radiation hybrid panel. The study population consisted of 142 sibling pairs concordant for ESRD from 121 African American families. The 142 sibling pairs were stratified into 78 pairs with hypertension- and chronic glomerulonephritis-associated ESRD and 64 with non-insulin-dependent diabetes mellitus-associated ESRD. Linkage analyses, using SIBPAL of SAGE, and exclusion analysis, using MAPMAKERS/SIBS, were performed. Linkage analysis of affected sibling pairs did not reveal any evidence of linkage of KLK3 to ESRD in all 142 sib-pairs or in the two stratified subsets. Exclusion analysis indicated that the KLK3 gene could be excluded from contributing to ESRD at a relative risk of 3 when the maximum log of the odds score of -2 was used as the criterion for exclusion. However, an association analysis using the relative predispositional effect technique showed that alleles 7 and 9 of KLK3b were consistently associated with ESRD. Alleles 7 and 9 were present in 11.2% and 10.8% of the 113 unrelated ESRD probands and in 6.6% and 6.6% of the 204 race-matched control subjects without renal disease (allele P=.0041 and .0016, respectively). Alleles 7 and 9 were also present in 13% and 10.4% of the proband's first siblings (allele P=.00014 and .0087, respectively). The association of KLK3b alleles with ESRD raises the possibility that polymorphisms in KLK3 may play a role in ESRD susceptibility. The lack of linkage might reflect our relatively small family set.

[1]  S. Rich,et al.  Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. , 1997, Kidney international.

[2]  S. Rich,et al.  Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. , 1996, Journal of the American Society of Nephrology : JASN.

[3]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[4]  K. Lange,et al.  Selected locus and multiple panel models for radiation hybrid mapping. , 1996, American journal of human genetics.

[5]  B. Morris,et al.  EXAMINATION OF THE ROLE OF NITRIC OXIDE SYNTHASE AND RENAL KALLIKREIN AS CANDIDATE GENES FOR ESSENTIAL HYPERTENSION , 1996, Clinical and experimental pharmacology & physiology.

[6]  L Kruglyak,et al.  Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.

[7]  L. Chao,et al.  Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats. , 1996, Human gene therapy.

[8]  L. Chao,et al.  Regulatory elements in the promoter region of the renal kallikrein gene in normotensive vs hypertensive rats. , 1995, Biochemical and biophysical research communications.

[9]  K Lange,et al.  Statistical methods for polyploid radiation hybrid mapping. , 1995, Genome research.

[10]  E. Lander,et al.  Complete multipoint sib-pair analysis of qualitative and quantitative traits. , 1995, American journal of human genetics.

[11]  L. Chao,et al.  Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. , 1995, Hypertension.

[12]  J. Clements The human kallikrein gene family: a diversity of expression and function , 1994, Molecular and Cellular Endocrinology.

[13]  K. Berg,et al.  No effect of TaqI polymorphism at the human renal kallikrein (KLK1) locus on normal blood pressure level or variability , 1993, Clinical genetics.

[14]  O. Carretero,et al.  The molecular biology of the kallikrein-kinin system: III. The human kallikrein gene family and kallikrein substrate. , 1993, Journal of hypertension.

[15]  D. Cox,et al.  The development of sequence-tagged sites for human chromosome 4. , 1993, Human molecular genetics.

[16]  O. Carretero,et al.  The molecular biology of the kallikrein-kinin system: I. General description, nomenclature and the mouse gene family. , 1993, Journal of hypertension.

[17]  B. Freedman,et al.  The familial risk of end-stage renal disease in African Americans. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  N. Seidah,et al.  Gene structure and chromosomal localization of plasma kallikrein. , 1991, Biochemistry.

[19]  T. Kurtz,et al.  Cosegregation of Blood Pressure with a Kallikrein Gene Family Polymorphism , 1991, Hypertension.

[20]  H. Payami,et al.  Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. , 1989, American journal of human genetics.

[21]  S. Hunt,et al.  A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. , 1989, Hypertension.

[22]  G. Sutherland,et al.  Structure and chromosomal localization of the human renal kallikrein gene. , 1988, Biochemistry.

[23]  R. Richards,et al.  Human prostate-specific antigen (APS) is a member of the glandular kallikrein gene family at 19q13. , 1988, Cytogenetics and cell genetics.

[24]  K. Fujikawa,et al.  Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. , 1986, Biochemistry.